متابعة القراءة
المقال الكامل على Unknown
SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
تحليل معلومات السوق
مدعوم بالذكاء الاصطناعي
لماذا هذا مهم
SCYNEXIS has been granted a 180-day extension by Nasdaq to regain compliance with the minimum bid price requirement, extending the deadline to June 15, 2026.
تأثير السوق
Market impact analysis based on neutral sentiment with 78% confidence.
المشاعر
Neutral
ثقة الذكاء الاصطناعي
78%
سياق المقال
ملاحظة: هذا مقتطف موجز للسياق. انقر أدناه لقراءة المقال الكامل على المصدر الأصلي.
JERSEY CITY, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that it has received an additional 180-calendar-day extension from the Nasdaq Stock Market (“Nasdaq”) to regain compliance with the minimum bid price requirement, as outlined in Nasdaq Listing Rule 5550(a)(2). The Company now has until June 15, 2026, to meet the require
المقال الأصلي منشور بواسطة
Unknown
في ديسمبر 22, 2025.
التحليل والرؤى المقدمة من AnalystMarkets AI.
التحليل والرؤى المقدمة من AnalystMarkets AI.